Moderator: Danisa A. Olumide, MD
37. Effect of topical steroid on swallowing following ACDF: results of a prospective randomized double blind control trial
Dan Stein, BS; Han Jo Kim, MD; Darren R. Lebl, MD; Russel C. Huang, MD; Renaud Lafage, MSc; Todd J. Albert, MD
Hospital for Special Surgery, New York, NY, US
FDA Device/Drug Status: This abstract does not discuss or include any applicable devices or drugs.
38. Prioritization of realignment associated with superior clinical outcomes for surgical cervical deformity patients
Katherine E. Pierce, BS1; Peter G. Passias, MD2; Renaud Lafage, MSc3; Dean Chou, MD4; Douglas C. Burton, MD5; Breton Line, BS6; Eric O. Klineberg, MD7; Robert A. Hart, MD8; Jeffrey L. Gum, MD9; Alan H. Daniels, MD10; Daniel M. Sciubba, MD17; Kojo Hamilton, MD11; Shay Bess, MD12; Themistocles S. Protopsaltis, MD13; Christopher I. Shaffrey, MD14; Frank J. Schwab, MD3; Justin K. Scheer, MD4; Justin S. Smith, MD, PhD15; Virginie Lafage, PhD3; Christopher P. Ames, MD4; International Spine Study Group16
1New York, NY, US; 2NY Spine Institute, NYU Langone Health, New York, NY, US; 3Hospital for Special Surgery, New York, NY, US; 4University of California San Francisco, San Francisco, CA, US; 5University of Kansas Medical Center, Kansas City, KS, US; 6Denver International Spine Center, Denver, CO, US; 7UC, Davis School of Medicine, Sacramento, CA, US; 8Swedish Neuroscience Institute, Seattle, WA, US; 9Norton Leatherman Spine Center, Louisville, KY, US; 10Warren Alpert Medical School of BU/RI Hospital, Providence, RI, US; 11University of Pittsburgh School of Medicine, Pittsburgh, PA, US; 12Denver, CO, US; 13Department of Orthopaedic Surgery, NYU Langone Orthopaedic Hospital, NYU Langone Health, New York, NY, US; 14University of Virginia, Charlottesville, VA, US; 15Health System, Charlottesville, VA, US; 16Brighton, CO, US; 17John Hopkins University, Baltimore, MD, US
FDA Device/Drug Status: This abstract does not discuss or include any applicable devices or drugs.
2019 Value Award Winner
39. Anterior cervical discectomy and fusions (ACDFs) at physician-owned hospitals: is it time to reconsider the sanctions of the Affordable Care Act (ACA)?
Azeem T. Malik, MBBS1; Frank M. Phillips, MD2; Sheldon Retchin, MD3; Wendy Xu, PhD3; Safdar N. Khan, MD1
1The Ohio State University Wexner Medical Center, Columbus, OH, US; 2Midwest Orthopaedics At Rush, Chicago, IL, US; 3Columbus, OH, US
FDA Device/Drug Status: This abstract does not discuss or include any applicable devices or drugs.
40. Posterior cervical fusion for fracture vs degenerative cervical spine disease: implications for a bundled payment model
Azeem T. Malik, MBBS; Elizabeth Yu, MD; Jeffery Kim, MD; Safdar N. Khan, MD
The Ohio State University Wexner Medical Center, Columbus, OH, US
FDA Device/Drug Status: This abstract does not discuss or include any applicable devices or drugs.
41. Reliability of the Neck Disability Index (NDI) and Japanese Orthopedic Association (JOA) questionnaires in adult cervical radiculopathy and myelopathy patients when administered by telephone or via online format
Gaurang Gupte, BS1; Jacob M. Buchowski, MD, MS2; Colleen M. Peters, MA3; Lukas P. Zebala, MD2
1St. Louis, MO, US; 2Washington University School of Medicine, Saint Louis, MO, US; 3Washington University School of Medicine, Department of Orthopedics, Saint Louis, MO, US
FDA Device/Drug Status: This abstract does not discuss or include any applicable devices or drugs.
42. The impact of surgical decompression on neck pain outcomes in patients with degenerative cervical myelopathy: results from the multicenter prospective AOSpine studies
Michel M. Schneider, MD1; Lindsay Tetreault2; Jetan H. Badhiwala, MD3; Mary P. Zhu2; Jefferson Wilson, MD, PhD, FRCSC4; Michael G. Fehlings, MD, PhD, FRCSC1
1Toronto Western Hospital, Toronto, ON, Canada; 2Toronto, ON, Canada; 3Division of Neurosurgery, Department of Surgery, University of Toronto, Toronto, ON, Canada; 4St. Michael's Hospital, University of Toronto, Toronto, ON, Canada
FDA Device/Drug Status: This abstract does not discuss or include any applicable devices or drugs.
43. Reduction in mortality in pediatric patients undergoing surgery for non-idiopathic scoliosis by implementing a multidisciplinary screening process
Lorenzo Deveza, MD, PhD1; John Heydemann, MD2; Benny Dahl, MD, PhD3
1Houston, TX, US; 2Texas Children's Hospital/Baylor College of Medicine, Houston, TX, US; 3Texas Children's Hospital, Houston, TX, US
FDA Device/Drug Status: This abstract does not discuss or include any applicable devices or drugs.
Discussion